FDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website

FDA Home Page | CDRH Home Page | Search | CDRH A-Z Index | Contact CDRH U.S. Food and Drug Administration Center for Devices and Radiological Health [Skip navigation]
horizonal rule

PMA Final Decisions Rendered for October 1999

related information

Some of the documents on this section of the CDRH Website are available only in PDF format and may not be accessible to those with certain disabilities. If you cannot access the documents you are interested in, please use the accessibility link for assistance. Below are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for October 1999. This list is generated on a monthly basis.

A PDF document that contains the "Approval letter and Summary of Safety and Effectiveness" is being added to this listing for each PMA. The PMA number will appear as a link if this document is available. Information about the PDF Reader is available.

PMA Original Approvals

PMA Original Approvals
APPLICATION NUMBER / DATE of APPROVAL DEVICE TRADE NAME COMPANY NAME CITY, STATE, & ZIP DEVICE DESCRIPTION / INDICATIONS

P990033

10/25/99

PepGen P-15

CeraMed Corporation

San Francisco, CA

94105-1635

Approval for PepGen P-15. This device is intended to be used for intrabony periodontal osseous defects due to moderate or severe periodontitis.

 

PMA Supplemental Approvals
APPLICATION NUMBER / DATE of APPROVAL DEVICE TRADE NAME COMPANY NAME CITY, STATE, & ZIP DEVICE DESCRIPTION / INDICATIONS

N50510/S094

10/7/99

Vitek® 2 Gram Negative Susceptibility Test for Amikacin

BioMerieux, Inc.

Hazelwood, MI

63042-2320

Approval for the addition of the antibiotic Amikacin at concentrations of 8, 16 and 64 m g/ml to the Vitek® 2 Gram Negative Susceptibility Test System. The device is indicated for use in Vitek® 2 Gram Negative Susceptibility Test Cards for the susceptibility testing of gram negative isolates to amikacin in the range of £ 2 to ³ 64 m g/ml.

P810002/S045

10/21/99

St. Jude Medical Mechanical Heart Valve

St. Jude Medical, Inc.

St. Paul, MN

55117

Approval for an increase of the orifice lot sizes during the pyrolytic carbon coating process at the Woodrige manufacturing facility.

P830026/S076*

10/29/99

Rx5000 Pacemaker Programmers

Guidant

Cardiac Rhythm Management

St. Paul, MN

55112-5798

Approval for a modification to the as shipped configuration for refurbished and repaired Rx5000 Pacemaker Programmers. Specifically, to offer the Triangular Chest Lead Cable Model 526-04 as a purchasable accessory and no longer include it with the shipped units.

P830039/S010

10/29/99

Omniscience® Cardiac Valve

Medical, Inc.

Inner Grove Heights, MN

55077

Approval for modifications to the Omni-Series Instructions for Handling and Use.

P830055/S064*

10/4/99

LCS Total Knee System

DePuy Orthopaedics, Inc.

Warsaw, IN

46581

Approval for a line extension consisting of the addition of LCS Revision System components include LCS cemented revision femoral, tibial tray, and augment components. The stems of the LCS revision tibial tray and femoral components are designed to allow for the use of ancillary stem extensions and sleeves from cleared and currently marketed devices. The device is indicated for the cemented revision of failed knee prostheses.

P830055/S065*

10/7/99

LCS Total Knee System

DePuy Orthopaedics, Inc.

Warsaw, IN

46581

Approval for a modification to the LCS Polyethylene Three-Pegged Patellar Component of the LCS Total Knee System. The current modification reduces the thickness of the three-pegged polyethylene patellar components by approximately two millimeters.

P830055/S066*

10/7/99

LCS Total Knee System

DePuy Orthopaedics, Inc.

Warsaw, IN

46581

Approval for a design modification to the LCS PS (Posterior Stabilized) Tibial Inserts of the LCS Total Knee System. The proposed modifications to the PS Tibial Inserts include a reduction in the height of the anterior lip and a change in the medial/lateral angle of the tibial spine.

P850064/S016

10/5/99

Life Pulse High Frequency Ventilator

Bunnell Inc.

Salt Lake City, UT

84115

Approval for the addition of three warnings.

P860004/S043*

10/29/99

Medtronic® Model 8711 Two Piece Intrathecal Catheter

Medtronic, Inc.

Shoreview, MN

55126-2983

Approval for a design change to the Model 8703W intraspinal catheter. The resulting catheter incorporates the same materials and basic design as Model 8703W except for a closed distal tip with six side holes instead of a single open tip. The device, as modified, will be marketed under the trade name Medtronic® Model 8711 Two Piece Intrathecal Catheter and is indicated for the containment and delivery of parenteral drugs to the intrathecal space of the spinal cord.

P890055/S011*

10/25/99

Arrow Model 3000/ 3000-16/3000-50 Implantable Infusion Pump

Therex Corporation

Walpole, MA

02081

Approval for the following modifications: 1) Increasing the Flex Tip Plus Intraspinal Catheter length; 2) Combining the infusion pump and the approved refill kit to facilitate the pump pre-implant procedure; 3) Adding a thermometer to the packaging for the monitoring of water bath temperature; and 4) Adding an informational chart of drug solution to the labeling.

P900056/S029

10/15/99

Rotablator® Rotational Angioplasty System

Boston Scientific Corporation

Redmond, WA

Approval for labeling changes to the Instructions for Use for the Rotablator System.

P910018/S001

10/29/99

Liposorber® LA-15 System

Kaneka Pharma America Corp.

New York, NY

10022

Approval for the following changes: 1) replacing the Membrane Filter Unit (MFU) located in the Liposorber LA-15 adsorption column, with the Cardioplegia Supor-1220 filter, which is bonded to the Extracoporeal Blood Tubing System, LT-MA2; 2) removing the maintenance unit and adding a clamp valve cover plate to the MA-01 Apheresis Unit; 3) making nine software changes, most of which are intended to either simplify procedures, ease the display of treatment parameters, or to make the therapy safer for the patients; and, 4) revising the Operators' Manual to incorporate the revisions associated with the hardware and software changes.

P910023/S044

10/13/99

Cadence® Tiered-Therapy Defibrillator System

St. Jude Medical

Sunnyvale, CA

94086-6527

Approval for an alternate manufacturing site for accessories and the DP-3238 Defibrillation Patch Lead located at St. Jude Medical, Cardiac Rhythm Management Division, 15900 Valley View Court, Sylmar, CA 91342-3577.

P930034/S012

10/21/99

SVS Apex Plus Excimer Laser Workstation, emphasis® discs K and L, and axicon

Summit Technology, Inc.

Waltham, MA

02154

Approval for the SVS Apex Plus Excimer Laser Workstation, emphasis® discs K and L, and axicon. These devices are indicated to perform hyperopic PRK.

P930034/S013

10/21/99

SVS Apex Plus Excimer Laser Workstation and emphasis® "M" discs

Summit Technology, Inc.

Waltham, MA

02154

Approval for the SVS Apex Plus Excimer Laser Workstation and emphasis® "M" discs (M00-M09) These devices are indicated to perform LASIK: 1) for the reduction or elimination of myopia ranging from 0.0 to –14.0 diopters (D) with or without astigmatism ranging from -0.5D to -5.0D; 2) in patients 18 years of age or older; and 3) in patients with documentation of a stable manifest refraction (± 0.5D) over the past year.

P940031/S020*

10/22/99

Pulsarmax™ Pacemakers, Models 1170, 1171, 1270/Pulsar™ pacemakers models 470, 970, 972, 1172, 1272/Discovery™ Pacemakers Models 1174, 1175, 1273, 1274, 1275/Meridian™ Pulse Generators Models 476, 976, 1176 and 1276

Guidant Corporation

St. Paul, MN

55112-5798

Approval for addition of a non-conducting epoxy preform between layers of the "triple stack".

P940031/S021*

10/20/99

Pulsar/Discovery/

Meridian (PDM) pacemakers with Software Application Model 2890 Revision 3.27

Guidant Corporation

St. Paul, MN

55112-5798

Approval for Software Application Model 2890 Revision 3.27 which removes automatic Minute Ventilation (MV) initialization, adds a "pop-up" warning on the programmer screen prior to manual MV initialization, and corrects several minor anomalies applicable to the entire PDM pacemaker line.

P950018/S003

10/12/99

Perfluoron

Alcon Laboratories, Inc.

Fort Worth, TX

76134-2099

Approval for a manufacturing site located at Alcon Laboratories, Inc., 6201 South Freeway, Fort Worth, Texas 76134-2099.

P950019/S008

10/4/99

Ray Threaded Fusion Cage (TFC)™ with instrumentation

United States Surgical Corporation

Norwalk, CT

06856

Approval for the Ray TFC™ Unite Device, a modified version of the approved Ray TFC™.

P950032/S014*

10/14/99

Apligraf (Graftskin)

Organogenesis, Inc.

Canton, MA

02021

Approval to introduce a new cell strain into the production of Apligraf (i.e., HEP 601).

P960004/S007**

10/21/99

ThinLine™ Models 430-10, 432-04, ThinLine™ EZ Model 438-10 and FINELINE™ Models 4450, 4451, 4460, 4461, 4462, 4475, and 4476 Endocardial Pacing Leads

Guidant Corporation

St. Paul, MN

55112

Approval for a manufacturing process change.

P970058/S005*

10/5/99

ImageChecker M1000

R2 Technology, Inc.

Los Altos, CA

94022

Approval for the addition of the Canon Model 300 digitizer as an optional digitizer for the ImageChecker M1000.

P990017/S001

10/20/99

ANCURE Tube and Bifurcated Systems and ANCURE Iliac Balloon Catheter

Guidant Corporation

Menlo Park, CA

94025

Approval for a new manufacturing facility located at Guidant Corporation, 1525 O'Brien Drive, Menlo Park, CA.

 

30-Day Notices (***135 Day Supplement was not required)
APPLICATION NUMBER & LTR DATE DEVICE TRADE NAME COMPANY NAME CITY, STATE, & ZIP COMMENTS

P860057/S012***

10/22/99

Carpentier-Edwards® Bioprosthetic Heart Valves, Various Models

Cardiovascular Group

Santa Ana, CA

92711-1150

The 30-Day Notice proposed a change in the quality control tests used to declare sterility of finished bioprosthetic heart valves. The change will allow for parametric release following terminal liquid sterilization in accordance with Documentation and Release Criteria for Liquid Chemical Sterilization Process.

P870056/S012***

10/22/99

Carpentier-Edwards® Bioprosthetic Heart Valves, Various Models

Cardiovascular Group

Santa Ana, CA

92711-1150

The 30-Day Notice proposed a change in the quality control tests used to declare sterility of finished bioprosthetic heart valves. The change will allow for parametric release following terminal liquid sterilization in accordance with Documentation and Release Criteria for Liquid Chemical Sterilization Process.

P870077/S010***

10/22/99

Carpentier-Edwards® Bioprosthetic Heart Valves, Various Models

Cardiovascular Group

Santa Ana, CA

92711-1150

The 30-Day Notice proposed a change in the quality control tests used to declare sterility of finished bioprosthetic heart valves. The change will allow for parametric release following terminal liquid sterilization in accordance with Documentation and Release Criteria for Liquid Chemical Sterilization Process.

P890043/S034***

10/12/99

Simpson Coronary AtheroCath-GTO®/Simpson Coronary AtheroCath-BANTAM™

Guidant Corporation

Temecula, CA

92591-4628

The 30-Day Notice requested implementation of two additional on-line inspections to the current manufacturing process to provide added assurance that the manufacturing step for attaching the nose cone to the housing has been performed correctly.

P920004/S011***

10/22/99

VasoSeal® (Vascular Hemostasis Device)

Datascope Corporation

Montvale, NJ

07645

The 30-Day Notice proposed a change in the quality control tests used to

Declare sterility of the VasoSeal® Needle Depth Indicator Kit. The change will allow for dosimetric release following gamma radiation sterilization in accordance with ANSI/AAMI/ISO 11137-1995 Requirements for validation and routine control – Radiation sterilization.

P810046/S199***

10/29/99

ACS OTW Photon™ Coronary Dilatation Catheter

Guidant Corporation

Temecula, CA

92591-4628

The 30-Day Notice requested: 1) modification of the manufacturing process by which the proximal adapter is bonded to the proximal portion of the ACS OTW PHOTON™ Coronary Dilatation Catheter; and 2) modification of the adaptation tensile test at the finished device audit process.

*Real-Time Review Supplement
**135 Day Supplement
***A 135 Day Supplement Was Not Required

Summary of PMA Originals & Supplements Approved
Originals: 1
Supplements: 23

Summary of PMA Originals Under Review
Total Under Review: 91
Total Active: 52
Total On Hold: 39
Number Greater Than 180 Days: 1

Summary of PMA Supplements Under Review
Total Under Review: 253
Total Active: 168
Total On Hold: 85
Number Greater Than 180 Days: 5

Summary of All PMA Submissions Received
Originals: 14
Supplements: 84

Summary of PMA Supplement PMA Approval/Denial Decision Times
Number of Approvals: 23
Number of Denials: 0
Average Days Fr Receipt to Decision (Total Time): 131

Updated 11/3/2000

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH